{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/2077559619",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1946973604"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#2077559619",
  "code": "2A81.8",
  "source": "http://id.who.int/icd/entity/2077559619",
  "classKind": "category",
  "postcoordinationScale": [
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/2077559619/postcoordinationScale/hasManifestation",
      "axisName": "http://id.who.int/icd/schema/hasManifestation",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "AllowAlways",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/322466810"
      ]
    }
  ],
  "title": {
    "@language": "en",
    "@value": "ALK-positive large B-cell lymphoma"
  },
  "definition": {
    "@language": "en",
    "@value": "A usually aggressive large B-cell lymphoma characterised by the presence of monomorphic immunoblast-like neoplastic B-lymphocytes in a sinusoidal growth pattern. The neoplastic B-lymphocytes express the ALK kinase but they lack the 2;5 translocation."
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "ALK-positive large B-cell lymphoma"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Diffuse large B-cell lymphoma, ALK positive"
      }
    }
  ]
}